Will cilostazol improve care for patients with intermittent claudication?

被引：0
作者：
不详
机构：
来源：
Drugs & Therapy Perspectives | 1999年 / 14卷 / 1期
关键词：
Human Immunodeficiency Virus Type; Clopidogrel; Peripheral Arterial Disease; Pentoxifylline; Cilostazol;
D O I：
10.2165/00042310-199914010-00001
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1 / 5
页数：4
相关论文
共 50 条
  • [11] Measuring treatment effects of cilostazol on clinical trial endpoints in patients with intermittent claudication
    Smith, JAM
    CLINICAL CARDIOLOGY, 2002, 25 (03) : 91 - 94
  • [12] Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication
    Lee, TM
    Su, SF
    Tsai, CH
    Lee, YT
    Wang, SS
    CLINICAL SCIENCE, 2001, 101 (03) : 305 - 311
  • [13] Effect of Cilostazol Prescribed in a Pragmatic Treatment Program for Intermittent Claudication
    Lee, Constance
    Nelson, Peter R.
    VASCULAR AND ENDOVASCULAR SURGERY, 2014, 48 (03) : 224 - 229
  • [14] Cilostazol treatment of claudication in diabetic patients
    Rendell, M
    Cariski, AT
    Hittel, N
    Zhang, P
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (08) : 479 - 487
  • [15] Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication
    Elam, MB
    Heckman, J
    Crouse, JR
    Hunninghake, DB
    Herd, JA
    Davidson, M
    Gordon, IL
    Bortey, EB
    Forbes, WP
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) : 1942 - 1947
  • [16] A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication
    Pande, Reena L.
    Hiatt, William R.
    Zhang, Peter
    Hittel, Norbert
    Creager, Mark A.
    VASCULAR MEDICINE, 2010, 15 (03) : 181 - 188
  • [17] The Limits of Evidence in Drug Approval and Availability: A Case Study of Cilostazol and Naftidrofuryl for the Treatment of Intermittent Claudication
    Hong, Haeyeon
    Mackey, William C.
    CLINICAL THERAPEUTICS, 2014, 36 (08) : 1290 - 1301
  • [18] Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6
    Lee, TM
    Su, SF
    Hwang, JJ
    Tseng, CD
    Chen, MF
    Lee, YT
    Wang, SS
    ATHEROSCLEROSIS, 2001, 158 (02) : 471 - 476
  • [19] Intermittent claudication
    Alan T. Hirsch
    Laura M. Reich
    Current Treatment Options in Cardiovascular Medicine, 2001, 3 (3) : 167 - 180
  • [20] Cilostazol is effective and safe option for the treatment of intermittent claudication Results of the NOCLAUD study
    Farkas Katalin
    Jarai Zoltan
    Kolossvary Endre
    ORVOSI HETILAP, 2017, 158 (04) : 123 - 128
12345